0 NASDAQ Companies - June 29, 2019Atara Biotherapeutics Presents Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)Read More
0 NASDAQ Companies - June 29, 2019Biogen announces European label update for SPINRAZA (nusinersen) which includes longer-term data across a broad range of ages and types of Spinal Muscular AtrophyRead More
0 TSX Venture News - June 29, 2019Novoheart Holdings Inc. Completes Acquisition of Xellera TherapeuticsRead More
